SCHEMBL10069575

SCHEMBL10069575

COC(=O)NCCOC(c1cccc(Cl)c1)c1cc(C(=O)O)cc(C(=O)OC)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
TSHR P16473 2/20 0.41
MAPK1 P28482 2/20 0.41
MAPT P10636 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
LMNA P02545 2/20 0.40
ADRB3 P13945 6/20 0.39
ADRB1 P08588 5/20 0.39
ADRB2 P07550 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
REN P00797 5/20 0.39
CYP3A4 P08684 2/20 0.39
RAB9A P51151 1/20 0.38
CASR P41180 1/20 0.37
GPR139 Q6DWJ6 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10068808 0.96 HTT (0.43) HTTMEN1KMT2ATSHRMAPK1
SCHEMBL2027362 0.93 HTT (0.43) HTTMEN1KMT2ATSHRMAPK1
SCHEMBL10068796 0.91 REN (0.40) HTTMEN1KMT2ATSHRMAPK1
SCHEMBL1568426 0.91 ADRB2 (0.47) HTTMEN1KMT2ATSHRMAPK1
SCHEMBL1567463 0.91 HTT (0.45) HTTMEN1KMT2ATSHRMAPK1
SCHEMBL1567460 0.91 HTT (0.45) HTTMEN1KMT2ATSHRMAPK1
SCHEMBL10068541 0.90 HTT (0.41) HTTMEN1KMT2ATSHRMAPK1
SCHEMBL10068970 0.90 HTT (0.41) HTTMEN1KMT2ATSHRMAPK1
SCHEMBL10068711 0.89 ADRB3 (0.44) HTTMEN1KMT2ATSHRMAPK1
SCHEMBL10069328 0.89 ADRB3 (0.42) HTTMEN1KMT2ATSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012019428-A1 BENZOHYDROL DERIVATIVES, A PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF 上海恒瑞医药有限公司 (CN) 2012-02-16 WO disclosed